Method for determining prognosis of HIV infected individuals
US7067246B1 · kind B1 · utility
0Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 20, 1999 |
| Grant date | Jun 27, 2006 |
| Priority date | — |
| Expiry date | Aug 20, 2019 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/163
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The serum levels of anti-tat antibodies, tat protein, and p24 protein are predictive of disease progression in HIV infected individuals and serve as prognostic markers. The present invention relates to a method for determining the prognosis of an HIV infected individual by measuring serum levels of one or more of these prognostic markers. In addition, a method for monitoring whether an HIV infected individual is in need of immunization with a tat vaccine and a method for monitoring the efficacy of immunization with a tat vaccine are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.